SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-008966
Filing Date
2021-05-05
Accepted
2021-05-05 07:14:01
Documents
17
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcel-20210505.htm   iXBRL 8-K 42152
2 EX-99.1 EARNINGS RELEASE 3-31-21 ex991earningsreleaseq12021.htm EX-99.1 110221
8 VERICEL LOGO vericellogoa261.jpg GRAPHIC 48734
  Complete submission text file 0001628280-21-008966.txt   380923

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20210505.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcel-20210505_cal.xml EX-101.CAL 967
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcel-20210505_def.xml EX-101.DEF 1963
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20210505_lab.xml EX-101.LAB 24583
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20210505_pre.xml EX-101.PRE 13186
9 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20210505_htm.xml XML 10750
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 21891146
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences